拉夏貝爾(06116.HK)擬獲高新集團提供5.5億元委託貸款
格隆匯11月27日丨拉夏貝爾(06116.HK)公佈,高新集團擬通過烏烏魯木齊銀行向公司提供人民幣5.5億元的委託貸款。公司直接附屬公司拉夏太倉擬以其持有的部分不動產為抵押物,以其持有的嘉裳倉儲100%股權為質押物,為該筆委託貸款提供資產抵押及質押。此次交易旨在以融資為目的,有效盤活公司長期存量資產,為主營業務發展提供資金支援。
若後續公司無法在規定的時間內償還貸款本金及利息,上述抵押及質押資產存在所有權變更的風險。公司將通過改善業務經營,加快存貨週轉,持續優化資金管理規劃和提升盈利能力,防範償債履約風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.